APO Research
Talk to an analyst

APO RESEARCH · REPORT

Treatment Planning Systems

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Treatment Planning Systems Market Outlook and Growth Opportunities 2026

1 January 2026195 pages

Choose your research edition.

Industry ResearchTreatment Planning Systems Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Treatment Planning Systems Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Treatment Planning Systems Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Treatment Planning Systems Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Treatment Planning Systems Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Treatment Planning Systems market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Treatment Planning Systems is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Treatment Planning Systems is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Treatment Planning Systems is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Treatment Planning Systems market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Treatment Planning Systems market include DOSIsoft, Brainlab, Philips, IBA, MIM Software, Accuray Incorporated, RaySearch Laboratories, ViewRay and Elekta, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Treatment Planning Systems market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Treatment Planning Systems and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Treatment Planning Systems revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Treatment Planning Systems market.

Treatment Planning Systems Segment by Company

DOSIsoft

Brainlab

Philips

IBA

MIM Software

Accuray Incorporated

RaySearch Laboratories

ViewRay

Elekta

Varian

Prowess

Linatech

Treatment Planning Systems Segment by Type

Cloud-based

On-premise

Treatment Planning Systems Segment by Application

Hospitals

Cancer Research Institute

Diagnostic and Treatment Centers

Others

Treatment Planning Systems Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Treatment Planning Systems status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Treatment Planning Systems key companies, revenue, market share, and recent developments.

3. To split the Treatment Planning Systems breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Treatment Planning Systems market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Treatment Planning Systems significant trends, drivers, influence factors in global and regions.

6. To analyze Treatment Planning Systems competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Treatment Planning Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Treatment Planning Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Treatment Planning Systems.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Treatment Planning Systems industry.

Chapter 3: Detailed analysis of Treatment Planning Systems company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Treatment Planning Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Treatment Planning Systems in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Treatment Planning Systems Industry Trends Table 2. Treatment Planning Systems Industry Drivers Table 3. Treatment Planning Systems Industry Opportunities and Challenges Table 4. Treatment Planning Systems Industry Restraints Table 5. Global Treatment Planning Systems Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Treatment Planning Systems Revenue Share by Company (2021-2026) Table 7. Global Treatment Planning Systems Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Treatment Planning Systems Key Company Manufacturing Base & Headquarters Table 9. Global Treatment Planning Systems Company, Product Type & Application Table 10. Global Treatment Planning Systems Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Treatment Planning Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cloud-based Table 15. Significant Companies of On-premise Table 16. Global Treatment Planning Systems Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Treatment Planning Systems Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Treatment Planning Systems Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Treatment Planning Systems Sales Value Share by Type (2021-2026) Table 20. Global Treatment Planning Systems Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospitals Table 22. Significant Companies of Cancer Research Institute Table 23. Significant Companies of Diagnostic and Treatment Centers Table 24. Significant Companies of Others Table 25. Global Treatment Planning Systems Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Treatment Planning Systems Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Treatment Planning Systems Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Treatment Planning Systems Sales Value Share by Application (2021-2026) Table 29. Global Treatment Planning Systems Sales Value Share by Application (2027-2032) Table 30. Global Treatment Planning Systems Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Treatment Planning Systems Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Treatment Planning Systems Sales Value Share by Region (2021-2026) Table 33. Global Treatment Planning Systems Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Treatment Planning Systems Sales Value Share by Region (2027-2032) Table 35. Global Treatment Planning Systems Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Treatment Planning Systems Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Treatment Planning Systems Sales Value Market Share by Country (2021-2026) Table 38. Global Treatment Planning Systems Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Treatment Planning Systems Sales Value Market Share by Country (2027-2032) Table 40. DOSIsoft Company Information Table 41. DOSIsoft Business Overview Table 42. DOSIsoft Treatment Planning Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. DOSIsoft Treatment Planning Systems Product Portfolio Table 44. DOSIsoft Recent Development Table 45. Brainlab Company Information Table 46. Brainlab Business Overview Table 47. Brainlab Treatment Planning Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Brainlab Treatment Planning Systems Product Portfolio Table 49. Brainlab Recent Development Table 50. Philips Company Information Table 51. Philips Business Overview Table 52. Philips Treatment Planning Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Philips Treatment Planning Systems Product Portfolio Table 54. Philips Recent Development Table 55. IBA Company Information Table 56. IBA Business Overview Table 57. IBA Treatment Planning Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. IBA Treatment Planning Systems Product Portfolio Table 59. IBA Recent Development Table 60. MIM Software Company Information Table 61. MIM Software Business Overview Table 62. MIM Software Treatment Planning Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. MIM Software Treatment Planning Systems Product Portfolio Table 64. MIM Software Recent Development Table 65. Accuray Incorporated Company Information Table 66. Accuray Incorporated Business Overview Table 67. Accuray Incorporated Treatment Planning Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Accuray Incorporated Treatment Planning Systems Product Portfolio Table 69. Accuray Incorporated Recent Development Table 70. RaySearch Laboratories Company Information Table 71. RaySearch Laboratories Business Overview Table 72. RaySearch Laboratories Treatment Planning Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. RaySearch Laboratories Treatment Planning Systems Product Portfolio Table 74. RaySearch Laboratories Recent Development Table 75. ViewRay Company Information Table 76. ViewRay Business Overview Table 77. ViewRay Treatment Planning Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. ViewRay Treatment Planning Systems Product Portfolio Table 79. ViewRay Recent Development Table 80. Elekta Company Information Table 81. Elekta Business Overview Table 82. Elekta Treatment Planning Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Elekta Treatment Planning Systems Product Portfolio Table 84. Elekta Recent Development Table 85. Varian Company Information Table 86. Varian Business Overview Table 87. Varian Treatment Planning Systems Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Varian Treatment Planning Systems Product Portfolio Table 89. Varian Recent Development Table 90. Prowess Company Information Table 91. Prowess Business Overview Table 92. Prowess Treatment Planning Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Prowess Treatment Planning Systems Product Portfolio Table 94. Prowess Recent Development Table 95. Linatech Company Information Table 96. Linatech Business Overview Table 97. Linatech Treatment Planning Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Linatech Treatment Planning Systems Product Portfolio Table 99. Linatech Recent Development Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. Treatment Planning Systems Product Image Figure 2. Global Treatment Planning Systems Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Treatment Planning Systems Market Size (2021-2032) & (US$ Million) Figure 4. Global Treatment Planning Systems Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cloud-based Image Figure 8. On-premise Image Figure 9. Global Treatment Planning Systems Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Treatment Planning Systems Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Treatment Planning Systems Sales Value Share by Type (2021-2032) Figure 12. Hospitals Image Figure 13. Cancer Research Institute Image Figure 14. Diagnostic and Treatment Centers Image Figure 15. Others Image Figure 16. Global Treatment Planning Systems Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Treatment Planning Systems Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Treatment Planning Systems Sales Value Share by Application (2021-2032) Figure 19. Global Treatment Planning Systems Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Treatment Planning Systems Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Treatment Planning Systems Sales Value (2021-2032) & (US$ Million) Figure 22. North America Treatment Planning Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Treatment Planning Systems Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Treatment Planning Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Treatment Planning Systems Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Treatment Planning Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Treatment Planning Systems Sales Value (2021-2032) & (US$ Million) Figure 28. South America Treatment Planning Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Treatment Planning Systems Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Treatment Planning Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Treatment Planning Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Treatment Planning Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Treatment Planning Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Treatment Planning Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Treatment Planning Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Treatment Planning Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Treatment Planning Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Treatment Planning Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Treatment Planning Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Treatment Planning Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Treatment Planning Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Treatment Planning Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Treatment Planning Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Treatment Planning Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Treatment Planning Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Treatment Planning Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Treatment Planning Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Treatment Planning Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Treatment Planning Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Treatment Planning Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Treatment Planning Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Treatment Planning Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Treatment Planning Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Treatment Planning Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Treatment Planning Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Treatment Planning Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Treatment Planning Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Treatment Planning Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On-premise
Applications
  • Hospitals
  • Cancer Research Institute
  • Diagnostic and Treatment Centers
  • Others
Companies covered
  • DOSIsoft
  • Brainlab
  • Philips
  • IBA
  • MIM Software
  • Accuray Incorporated
  • RaySearch Laboratories
  • ViewRay
  • Elekta
  • Varian
  • Prowess
  • Linatech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Treatment Planning Systems Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Treatment Planning Systems Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Treatment Planning Systems Market Dynamics
  1. 2.1 Treatment Planning Systems Industry Trends
  2. 2.2 Treatment Planning Systems Industry Drivers
  3. 2.3 Treatment Planning Systems Industry Opportunities and Challenges
  4. 2.4 Treatment Planning Systems Industry Restraints
3 Treatment Planning Systems Market by Company
  1. 3.1 Global Treatment Planning Systems Company Revenue Ranking in 2025
  2. 3.2 Global Treatment Planning Systems Revenue by Company (2021-2026)
  3. 3.3 Global Treatment Planning Systems Company Ranking (2024-2026)
  4. 3.4 Global Treatment Planning Systems Company Manufacturing Base and Headquarters
  5. 3.5 Global Treatment Planning Systems Company Product Type and Application
  6. 3.6 Global Treatment Planning Systems Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Treatment Planning Systems Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Treatment Planning Systems Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Treatment Planning Systems Market by Type
  1. 4.1 Treatment Planning Systems Type Introduction
  2. 4.1.1 Cloud-based
  3. 4.1.2 On-premise
  4. 4.2 Global Treatment Planning Systems Sales Value by Type
  5. 4.2.1 Global Treatment Planning Systems Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Treatment Planning Systems Sales Value by Type (2021-2032)
  7. 4.2.3 Global Treatment Planning Systems Sales Value Share by Type (2021-2032)
5 Treatment Planning Systems Market by Application
  1. 5.1 Treatment Planning Systems Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Cancer Research Institute
  4. 5.1.3 Diagnostic and Treatment Centers
  5. 5.1.4 Others
  6. 5.2 Global Treatment Planning Systems Sales Value by Application
  7. 5.2.1 Global Treatment Planning Systems Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Treatment Planning Systems Sales Value by Application (2021-2032)
  9. 5.2.3 Global Treatment Planning Systems Sales Value Share by Application (2021-2032)
6 Treatment Planning Systems Regional Value Analysis
  1. 6.1 Global Treatment Planning Systems Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Treatment Planning Systems Sales Value by Region (2021-2032)
  3. 6.2.1 Global Treatment Planning Systems Sales Value by Region: 2021-2026
  4. 6.2.2 Global Treatment Planning Systems Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Treatment Planning Systems Sales Value (2021-2032)
  7. 6.3.2 North America Treatment Planning Systems Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Treatment Planning Systems Sales Value (2021-2032)
  10. 6.4.2 Europe Treatment Planning Systems Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Treatment Planning Systems Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Treatment Planning Systems Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Treatment Planning Systems Sales Value (2021-2032)
  16. 6.6.2 South America Treatment Planning Systems Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Treatment Planning Systems Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Treatment Planning Systems Sales Value Share by Country, 2025 VS 2032
7 Treatment Planning Systems Country-level Value Analysis
  1. 7.1 Global Treatment Planning Systems Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Treatment Planning Systems Sales Value by Country (2021-2032)
  3. 7.2.1 Global Treatment Planning Systems Sales Value by Country (2021-2026)
  4. 7.2.2 Global Treatment Planning Systems Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Treatment Planning Systems Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Treatment Planning Systems Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Treatment Planning Systems Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Treatment Planning Systems Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Treatment Planning Systems Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Treatment Planning Systems Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Treatment Planning Systems Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Treatment Planning Systems Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Treatment Planning Systems Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Treatment Planning Systems Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Treatment Planning Systems Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Treatment Planning Systems Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Treatment Planning Systems Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Treatment Planning Systems Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Treatment Planning Systems Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Treatment Planning Systems Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Treatment Planning Systems Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Treatment Planning Systems Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Treatment Planning Systems Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Treatment Planning Systems Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Treatment Planning Systems Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Treatment Planning Systems Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Treatment Planning Systems Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Treatment Planning Systems Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Treatment Planning Systems Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Treatment Planning Systems Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Treatment Planning Systems Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Treatment Planning Systems Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Treatment Planning Systems Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Treatment Planning Systems Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 DOSIsoft
  2. 8.1.1 DOSIsoft Company Information
  3. 8.1.2 DOSIsoft Business Overview
  4. 8.1.3 DOSIsoft Treatment Planning Systems Revenue and Gross Margin (2021-2026)
  5. 8.1.4 DOSIsoft Treatment Planning Systems Product Portfolio
  6. 8.1.5 DOSIsoft Recent Developments
  7. 8.2 Brainlab
  8. 8.2.1 Brainlab Company Information
  9. 8.2.2 Brainlab Business Overview
  10. 8.2.3 Brainlab Treatment Planning Systems Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Brainlab Treatment Planning Systems Product Portfolio
  12. 8.2.5 Brainlab Recent Developments
  13. 8.3 Philips
  14. 8.3.1 Philips Company Information
  15. 8.3.2 Philips Business Overview
  16. 8.3.3 Philips Treatment Planning Systems Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Philips Treatment Planning Systems Product Portfolio
  18. 8.3.5 Philips Recent Developments
  19. 8.4 IBA
  20. 8.4.1 IBA Company Information
  21. 8.4.2 IBA Business Overview
  22. 8.4.3 IBA Treatment Planning Systems Revenue and Gross Margin (2021-2026)
  23. 8.4.4 IBA Treatment Planning Systems Product Portfolio
  24. 8.4.5 IBA Recent Developments
  25. 8.5 MIM Software
  26. 8.5.1 MIM Software Company Information
  27. 8.5.2 MIM Software Business Overview
  28. 8.5.3 MIM Software Treatment Planning Systems Revenue and Gross Margin (2021-2026)
  29. 8.5.4 MIM Software Treatment Planning Systems Product Portfolio
  30. 8.5.5 MIM Software Recent Developments
  31. 8.6 Accuray Incorporated
  32. 8.6.1 Accuray Incorporated Company Information
  33. 8.6.2 Accuray Incorporated Business Overview
  34. 8.6.3 Accuray Incorporated Treatment Planning Systems Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Accuray Incorporated Treatment Planning Systems Product Portfolio
  36. 8.6.5 Accuray Incorporated Recent Developments
  37. 8.7 RaySearch Laboratories
  38. 8.7.1 RaySearch Laboratories Company Information
  39. 8.7.2 RaySearch Laboratories Business Overview
  40. 8.7.3 RaySearch Laboratories Treatment Planning Systems Revenue and Gross Margin (2021-2026)
  41. 8.7.4 RaySearch Laboratories Treatment Planning Systems Product Portfolio
  42. 8.7.5 RaySearch Laboratories Recent Developments
  43. 8.8 ViewRay
  44. 8.8.1 ViewRay Company Information
  45. 8.8.2 ViewRay Business Overview
  46. 8.8.3 ViewRay Treatment Planning Systems Revenue and Gross Margin (2021-2026)
  47. 8.8.4 ViewRay Treatment Planning Systems Product Portfolio
  48. 8.8.5 ViewRay Recent Developments
  49. 8.9 Elekta
  50. 8.9.1 Elekta Company Information
  51. 8.9.2 Elekta Business Overview
  52. 8.9.3 Elekta Treatment Planning Systems Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Elekta Treatment Planning Systems Product Portfolio
  54. 8.9.5 Elekta Recent Developments
  55. 8.10 Varian
  56. 8.10.1 Varian Company Information
  57. 8.10.2 Varian Business Overview
  58. 8.10.3 Varian Treatment Planning Systems Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Varian Treatment Planning Systems Product Portfolio
  60. 8.10.5 Varian Recent Developments
  61. 8.11 Prowess
  62. 8.11.1 Prowess Company Information
  63. 8.11.2 Prowess Business Overview
  64. 8.11.3 Prowess Treatment Planning Systems Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Prowess Treatment Planning Systems Product Portfolio
  66. 8.11.5 Prowess Recent Developments
  67. 8.12 Linatech
  68. 8.12.1 Linatech Company Information
  69. 8.12.2 Linatech Business Overview
  70. 8.12.3 Linatech Treatment Planning Systems Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Linatech Treatment Planning Systems Product Portfolio
  72. 8.12.5 Linatech Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst